Physician profile
Chadi Kaba
NPI 1811945694
$1,454.77
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $759 · 2020: $576 · 2021: $120.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $382.21 | 2019-2021 | |
| Novo Nordisk INC | $231.16 | 2019-2020 | |
| Glaxosmithkline, LLC. | $213.95 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $118.81 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $89.72 | 2020-2021 | |
| Lilly USA, LLC | $78.55 | 2019-2020 | |
| Amgen INC. | $76.34 | 2019-2020 | |
| Astellas Pharma US INC | $57.80 | 2019 | |
| Sanofi-Aventis U.S. LLC | $46.44 | 2020-2021 | |
| Abbvie INC. | $36.68 | 2020 | |
| Merck Sharp & Dohme LLC | $35.29 | 2019 | |
| Novartis Pharmaceuticals Corporation | $28.74 | 2019-2021 | |
| Mylan Specialty L.P. | $22.20 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $20.33 | 2019 | |
| Sanofi Pasteur INC. | $16.55 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chadi Kaba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.